FDA seeks more data on MannKind's inhaled insulin | Reuters

Links shared publicly online about this topic.

  • 1,311
    total visits

FDA seeks more data on MannKind's inhaled insulin | Reuters

reuters.com

BOSTON (Reuters) - U.S. regulators have requested more information on an inhaled insulin device being developed by MannKind Corp, sending the company's shares down 24.7 percent. MannKind said on Monday

View full resource at reuters.com

Tags: Diabetes, Insulin, FDA

  • Share

Most Recently Shared on March 16, 2010 at 4:30 am By:

hrana Hisham Rana, MD

News: FDA seeks more data on MannKind's inhaled insulin http://bit.ly/9kiGXu - #diabetes #health

2 years ago...

FDA seeks more data on MannKind's inhaled insulin | Reuters

feeds.reuters.com — “BOSTON (Reuters) - U.S. regulators have requested more information on an inhaled insulin device being developed by MannKind Corp, sending the company's shares down 24.7 percent. MannKind said on MondayView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on March 16, 2010 at 7:27 am By:

FDA seeks more data on MannKind's inhaled insulin | Reuters

feeds.reuters.com — “BOSTON (Reuters) - U.S. regulators have requested more information on an inhaled insulin device being developed by MannKind Corp, sending the company's shares down 24.7 percent. MannKind said on MondayView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 8:51 pm By:

UPDATE 4-FDA seeks more data on MannKind's inhaled insulin | Reuters

reuters.com — “* FDA requests available data on Afrezza clinical utility * Seeks comparability information on commercial version * Asks for updated safety data; cites no safety concerns * Shares fall 24.7 pctView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 2:20 pm By:

ReutersLisaRx Lisa Richwine Health Communicator

MNKD says FDA requests include currently available data that back clinical utility of Afrezza inhaled insulin http://link.reuters.com/gef93j

2 years ago...

Advertisement